Last reviewed · How we verify

NCT05257278: UNITE

MonoPlus® in Orthopedic Surgery

Completed Last updated 19 September 2024
What this trial tests

trial testing MonoPlus® in Orthopedic Surgery in 140 participants. Completed in 7 July 2024.

Timeline
18 January 2022
Primary endpoint
7 July 2023
7 July 2024

Quick facts

Lead sponsorAesculap AG
StatusCompleted
Study typeOBSERVATIONAL
Enrollment140
Start date18 January 2022
Primary completion7 July 2023
Estimated completion7 July 2024
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Aesculap AG — full company profile →

Who can join

18 and older, any sex, with Orthopedic Surgery or Soft Tissue Approximation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Single-center postmarket clinical follow-up study (PMCF) on the performance and safety of MonoPlus® in patients undergoing orthopedic surgery

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Orthopedic Surgery

Currently open trials in the same condition.

Other Aesculap AG trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05257278.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing